In the entire cohort of primary tumours, we disclosed three variants—deletions in BCLAF1 and OVCH2 and substitution in OR2T35—and 26 mutated genes that were mutated in >30% of all cases, being part of a global mutational signature of HPV+ TSCC/BOTSCC. The gene discussed is OVCH2; the disease is neoplasm.